Rep. Amy L. Grant supports HB3454 updating epinephrine device regulations
Rep. Amy L. Grant (R-47th) supported HB3454, legislation to update policies on epinephrine delivery devices, during the 104th General Assembly session on May 31, 2026. The Illinois House passed the bill unanimously by a vote of 116-0.
The legislative summary describes the measure as relating to "EPINEPHRINE DELIVERY DEVICE."
Below is an overview based on the bill language, including clarifications for its main components.
This legislation modifies various Illinois statutes, replacing references to "epinephrine auto-injector" or "epinephrine injector" with "FDA approved epinephrine delivery device or product." It renames the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act, and sets new rules for law enforcement and school staff training and authorization to use these devices for anaphylaxis cases. The bill provides liability protections for staff who administer the devices in good faith, and requires facilities to establish protocols for acquiring, storing, and using them. It also requires reporting of device administration incidents to the State Board of Education, clarifies cost responsibilities for acquisition and training, ensures health insurance coverage for minors, and amends related public health and emergency response rules.
HB3454's recorded action notes 'Senate Floor Amendment No. 2 House Concurs.'
Grant earned her BS from the University of Pittsburgh in 1980.
A member of the Republican Party, Grant was elected in 2023 to represent the 47th House District in the Illinois State House, succeeding Deanne Mazzochi.
In Illinois, proposed laws follow a multi-step lawmaking process that begins with introduction in the House or Senate, continues through committee hearings, floor debates, and passage by both chambers, before being sent to the governor for approval or veto. The General Assembly meets biennially, with thousands of bills introduced each session but only a portion make it into law.